nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—Blood disorder—Metformin—metabolic syndrome X	0.0538	0.0555	CcSEcCtD
Flecainide—Neuropathy—Metformin—metabolic syndrome X	0.0422	0.0436	CcSEcCtD
Flecainide—Lightheadedness—Metformin—metabolic syndrome X	0.0402	0.0415	CcSEcCtD
Flecainide—Sweating increased—Metformin—metabolic syndrome X	0.0274	0.0284	CcSEcCtD
Flecainide—Angina pectoris—Metformin—metabolic syndrome X	0.0274	0.0284	CcSEcCtD
Flecainide—Neuropathy peripheral—Metformin—metabolic syndrome X	0.0246	0.0254	CcSEcCtD
Flecainide—Bradycardia—Metformin—metabolic syndrome X	0.023	0.0237	CcSEcCtD
Flecainide—Hypoaesthesia—Metformin—metabolic syndrome X	0.0224	0.0232	CcSEcCtD
Flecainide—Eye disorder—Metformin—metabolic syndrome X	0.0211	0.0218	CcSEcCtD
Flecainide—Flushing—Metformin—metabolic syndrome X	0.0209	0.0216	CcSEcCtD
Flecainide—Immune system disorder—Metformin—metabolic syndrome X	0.0204	0.021	CcSEcCtD
Flecainide—Flatulence—Metformin—metabolic syndrome X	0.0193	0.02	CcSEcCtD
Flecainide—Dysgeusia—Metformin—metabolic syndrome X	0.0192	0.0199	CcSEcCtD
Flecainide—Vision blurred—Metformin—metabolic syndrome X	0.0185	0.0191	CcSEcCtD
Flecainide—Tremor—Metformin—metabolic syndrome X	0.0184	0.019	CcSEcCtD
Flecainide—Ill-defined disorder—Metformin—metabolic syndrome X	0.0182	0.0188	CcSEcCtD
Flecainide—Malaise—Metformin—metabolic syndrome X	0.0177	0.0183	CcSEcCtD
Flecainide—Syncope—Metformin—metabolic syndrome X	0.0176	0.0182	CcSEcCtD
Flecainide—Palpitations—Metformin—metabolic syndrome X	0.0173	0.0179	CcSEcCtD
Flecainide—Loss of consciousness—Metformin—metabolic syndrome X	0.0172	0.0178	CcSEcCtD
Flecainide—Hypertension—Metformin—metabolic syndrome X	0.0169	0.0175	CcSEcCtD
Flecainide—Myalgia—Metformin—metabolic syndrome X	0.0167	0.0173	CcSEcCtD
Flecainide—Chest pain—Metformin—metabolic syndrome X	0.0167	0.0173	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.0166	0.0171	CcSEcCtD
Flecainide—Discomfort—Metformin—metabolic syndrome X	0.0165	0.0171	CcSEcCtD
Flecainide—Oedema—Metformin—metabolic syndrome X	0.016	0.0166	CcSEcCtD
Flecainide—Shock—Metformin—metabolic syndrome X	0.0158	0.0163	CcSEcCtD
Flecainide—Nervous system disorder—Metformin—metabolic syndrome X	0.0157	0.0162	CcSEcCtD
Flecainide—Thrombocytopenia—Metformin—metabolic syndrome X	0.0157	0.0162	CcSEcCtD
Flecainide—Skin disorder—Metformin—metabolic syndrome X	0.0156	0.0161	CcSEcCtD
Flecainide—Hyperhidrosis—Metformin—metabolic syndrome X	0.0155	0.016	CcSEcCtD
Flecainide—Anorexia—Metformin—metabolic syndrome X	0.0153	0.0158	CcSEcCtD
Flecainide—Hypotension—Metformin—metabolic syndrome X	0.015	0.0155	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.0146	0.0151	CcSEcCtD
Flecainide—Paraesthesia—Metformin—metabolic syndrome X	0.0144	0.0149	CcSEcCtD
Flecainide—Dyspnoea—Metformin—metabolic syndrome X	0.0143	0.0148	CcSEcCtD
Flecainide—Somnolence—Metformin—metabolic syndrome X	0.0142	0.0147	CcSEcCtD
Flecainide—Dyspepsia—Metformin—metabolic syndrome X	0.0141	0.0146	CcSEcCtD
Flecainide—Decreased appetite—Metformin—metabolic syndrome X	0.0139	0.0144	CcSEcCtD
Flecainide—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.0138	0.0143	CcSEcCtD
Flecainide—Fatigue—Metformin—metabolic syndrome X	0.0138	0.0143	CcSEcCtD
Flecainide—Constipation—Metformin—metabolic syndrome X	0.0137	0.0142	CcSEcCtD
Flecainide—Feeling abnormal—Metformin—metabolic syndrome X	0.0132	0.0136	CcSEcCtD
Flecainide—Gastrointestinal pain—Metformin—metabolic syndrome X	0.0131	0.0135	CcSEcCtD
Flecainide—Urticaria—Metformin—metabolic syndrome X	0.0127	0.0131	CcSEcCtD
Flecainide—Abdominal pain—Metformin—metabolic syndrome X	0.0127	0.0131	CcSEcCtD
Flecainide—Asthenia—Metformin—metabolic syndrome X	0.0115	0.0119	CcSEcCtD
Flecainide—Pruritus—Metformin—metabolic syndrome X	0.0113	0.0117	CcSEcCtD
Flecainide—Diarrhoea—Metformin—metabolic syndrome X	0.011	0.0113	CcSEcCtD
Flecainide—Dizziness—Metformin—metabolic syndrome X	0.0106	0.0109	CcSEcCtD
Flecainide—Vomiting—Metformin—metabolic syndrome X	0.0102	0.0105	CcSEcCtD
Flecainide—Rash—Metformin—metabolic syndrome X	0.0101	0.0104	CcSEcCtD
Flecainide—Dermatitis—Metformin—metabolic syndrome X	0.0101	0.0104	CcSEcCtD
Flecainide—Headache—Metformin—metabolic syndrome X	0.01	0.0104	CcSEcCtD
Flecainide—Nausea—Metformin—metabolic syndrome X	0.00951	0.00983	CcSEcCtD
Flecainide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—EPHX2—metabolic syndrome X	0.00365	0.113	CbGpPWpGaD
Flecainide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—EPHX2—metabolic syndrome X	0.00328	0.101	CbGpPWpGaD
Flecainide—CYP2D6—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.00171	0.053	CbGpPWpGaD
Flecainide—CYP2C9—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.0017	0.0526	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—FMO3—metabolic syndrome X	0.00111	0.0342	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.00107	0.033	CbGpPWpGaD
Flecainide—CYP2C9—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.00082	0.0254	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—IGF2—metabolic syndrome X	0.000789	0.0244	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.000781	0.0242	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—EPHX2—metabolic syndrome X	0.000757	0.0234	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.000714	0.0221	CbGpPWpGaD
Flecainide—CYP2D6—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.0006	0.0186	CbGpPWpGaD
Flecainide—CYP2C9—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.000595	0.0184	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—INS—metabolic syndrome X	0.000524	0.0162	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—IGF1—metabolic syndrome X	0.000506	0.0157	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—GCK—metabolic syndrome X	0.000505	0.0156	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—FABP4—metabolic syndrome X	0.000463	0.0143	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00041	0.0127	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—HDAC3—metabolic syndrome X	0.000382	0.0118	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—FMO3—metabolic syndrome X	0.000319	0.00986	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—FMO3—metabolic syndrome X	0.000316	0.00977	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—FMO3—metabolic syndrome X	0.000314	0.00972	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—FABP4—metabolic syndrome X	0.000314	0.0097	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—FMO3—metabolic syndrome X	0.000312	0.00964	CbGpPWpGaD
Flecainide—CYP2D6—Melatonin metabolism and effects—APOE—metabolic syndrome X	0.000309	0.00956	CbGpPWpGaD
Flecainide—SCN5A—Cardiac Progenitor Differentiation—TGFB1—metabolic syndrome X	0.000304	0.00939	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—GCK—metabolic syndrome X	0.000296	0.00916	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—GGT1—metabolic syndrome X	0.000292	0.00903	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—NR3C1—metabolic syndrome X	0.000291	0.00899	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.000284	0.00879	CbGpPWpGaD
Flecainide—CYP2D6—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00028	0.00867	CbGpPWpGaD
Flecainide—CYP2C9—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.000278	0.00859	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—SREBF1—metabolic syndrome X	0.000266	0.00822	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—HDAC3—metabolic syndrome X	0.000259	0.008	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—ADIPOQ—metabolic syndrome X	0.000244	0.00755	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—PLA2G4A—metabolic syndrome X	0.000241	0.00745	CbGpPWpGaD
Flecainide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.000235	0.00727	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—SLC2A4—metabolic syndrome X	0.00023	0.00713	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—GCK—metabolic syndrome X	0.000201	0.00621	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—LPL—metabolic syndrome X	0.000181	0.00559	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—SREBF1—metabolic syndrome X	0.00018	0.00557	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—CD36—metabolic syndrome X	0.000172	0.00531	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—ADIPOQ—metabolic syndrome X	0.000165	0.00512	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PPARA—metabolic syndrome X	0.00016	0.00494	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—SLC2A4—metabolic syndrome X	0.000156	0.00483	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—LEP—metabolic syndrome X	0.000152	0.00469	CbGpPWpGaD
Flecainide—CYP2C9—Arachidonic acid metabolism—PTGS2—metabolic syndrome X	0.000136	0.0042	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—PPARG—metabolic syndrome X	0.000132	0.00408	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—INS—metabolic syndrome X	0.000129	0.004	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—LPL—metabolic syndrome X	0.000123	0.00379	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—TNF—metabolic syndrome X	0.00012	0.0037	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—CD36—metabolic syndrome X	0.000116	0.0036	CbGpPWpGaD
Flecainide—CYP2D6—Biological oxidations—GGT1—metabolic syndrome X	0.00011	0.00339	CbGpPWpGaD
Flecainide—CYP2C9—Biological oxidations—GGT1—metabolic syndrome X	0.000109	0.00336	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PPARA—metabolic syndrome X	0.000108	0.00335	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000108	0.00335	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—LEP—metabolic syndrome X	0.000103	0.00318	CbGpPWpGaD
Flecainide—SCN5A—SIDS Susceptibility Pathways—IL6—metabolic syndrome X	9.64e-05	0.00298	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—PPARG—metabolic syndrome X	8.95e-05	0.00277	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—INS—metabolic syndrome X	8.78e-05	0.00271	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	8.65e-05	0.00267	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	8.2e-05	0.00254	CbGpPWpGaD
Flecainide—SCN4A—Axon guidance—IL6—metabolic syndrome X	7.93e-05	0.00245	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TGFB1—metabolic syndrome X	7.51e-05	0.00232	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	7.13e-05	0.00221	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—TNF—metabolic syndrome X	7.01e-05	0.00217	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	6.97e-05	0.00216	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	6.75e-05	0.00209	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	6.68e-05	0.00207	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	6.21e-05	0.00192	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—IL6—metabolic syndrome X	5.66e-05	0.00175	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	5.54e-05	0.00171	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	5.5e-05	0.0017	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—FMO3—metabolic syndrome X	5.45e-05	0.00169	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—FMO3—metabolic syndrome X	5.41e-05	0.00167	CbGpPWpGaD
Flecainide—SCN5A—Axon guidance—IL6—metabolic syndrome X	5.37e-05	0.00166	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	5.34e-05	0.00165	CbGpPWpGaD
Flecainide—SCN4A—Developmental Biology—AKT1—metabolic syndrome X	5.22e-05	0.00161	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	5.12e-05	0.00158	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TGFB1—metabolic syndrome X	5.09e-05	0.00157	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	4.97e-05	0.00154	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—MLXIPL—metabolic syndrome X	4.86e-05	0.0015	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—EPHX2—metabolic syndrome X	4.86e-05	0.0015	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	4.83e-05	0.00149	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—MLXIPL—metabolic syndrome X	4.82e-05	0.00149	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—EPHX2—metabolic syndrome X	4.82e-05	0.00149	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—TNF—metabolic syndrome X	4.75e-05	0.00147	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—G6PC2—metabolic syndrome X	4.57e-05	0.00141	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—G6PC2—metabolic syndrome X	4.53e-05	0.0014	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	4.31e-05	0.00133	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	4.17e-05	0.00129	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—FABP4—metabolic syndrome X	3.89e-05	0.0012	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—FABP4—metabolic syndrome X	3.85e-05	0.00119	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—IL6—metabolic syndrome X	3.84e-05	0.00119	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	3.68e-05	0.00114	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HSD11B1—metabolic syndrome X	3.65e-05	0.00113	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	3.54e-05	0.00109	CbGpPWpGaD
Flecainide—SCN5A—Developmental Biology—AKT1—metabolic syndrome X	3.54e-05	0.00109	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	3.44e-05	0.00106	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	3.38e-05	0.00105	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—G6PD—metabolic syndrome X	3.28e-05	0.00102	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—G6PD—metabolic syndrome X	3.25e-05	0.00101	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	3.21e-05	0.000993	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	3.2e-05	0.000991	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HDAC3—metabolic syndrome X	3.18e-05	0.000982	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GCKR—metabolic syndrome X	3.13e-05	0.000968	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LPA—metabolic syndrome X	3.13e-05	0.000968	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GCKR—metabolic syndrome X	3.1e-05	0.00096	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LPA—metabolic syndrome X	3.1e-05	0.00096	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	3.03e-05	0.000938	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	3.01e-05	0.00093	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APOA5—metabolic syndrome X	3e-05	0.000928	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	2.99e-05	0.000923	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APOA5—metabolic syndrome X	2.98e-05	0.00092	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	2.89e-05	0.000894	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.83e-05	0.000876	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	2.8e-05	0.000866	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	2.79e-05	0.000863	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	2.77e-05	0.000856	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	2.5e-05	0.000774	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GCK—metabolic syndrome X	2.49e-05	0.000769	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LIPC—metabolic syndrome X	2.49e-05	0.000769	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	2.48e-05	0.000768	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APOC3—metabolic syndrome X	2.47e-05	0.000765	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	2.47e-05	0.000763	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LIPC—metabolic syndrome X	2.47e-05	0.000763	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GCK—metabolic syndrome X	2.47e-05	0.000763	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APOC3—metabolic syndrome X	2.45e-05	0.000758	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CETP—metabolic syndrome X	2.4e-05	0.000742	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CETP—metabolic syndrome X	2.38e-05	0.000736	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	2.3e-05	0.000711	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	2.28e-05	0.000705	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	2.23e-05	0.00069	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	2.22e-05	0.000686	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	2.21e-05	0.000684	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	2.17e-05	0.000671	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GOT2—metabolic syndrome X	2.17e-05	0.000671	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	2.15e-05	0.000665	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GOT2—metabolic syndrome X	2.15e-05	0.000665	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.94e-05	0.0006	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.93e-05	0.000598	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.93e-05	0.000598	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	1.92e-05	0.000593	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	1.92e-05	0.000593	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.87e-05	0.000579	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.87e-05	0.000579	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GOT1—metabolic syndrome X	1.86e-05	0.000574	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—GGT1—metabolic syndrome X	1.86e-05	0.000574	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.59e-05	0.000492	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APOB—metabolic syndrome X	1.58e-05	0.000487	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.55e-05	0.000478	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	1.53e-05	0.000474	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.52e-05	0.000469	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—LPL—metabolic syndrome X	1.51e-05	0.000465	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.44e-05	0.000446	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—CD36—metabolic syndrome X	1.43e-05	0.000442	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPARA—metabolic syndrome X	1.34e-05	0.000415	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPARA—metabolic syndrome X	1.33e-05	0.000411	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AGT—metabolic syndrome X	1.3e-05	0.000402	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AGT—metabolic syndrome X	1.29e-05	0.000398	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APOE—metabolic syndrome X	1.27e-05	0.000394	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APOE—metabolic syndrome X	1.26e-05	0.00039	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—APOA1—metabolic syndrome X	1.26e-05	0.000389	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—APOA1—metabolic syndrome X	1.25e-05	0.000386	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PPARG—metabolic syndrome X	1.11e-05	0.000343	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PPARG—metabolic syndrome X	1.1e-05	0.00034	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—INS—metabolic syndrome X	1.09e-05	0.000336	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—INS—metabolic syndrome X	1.08e-05	0.000333	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—ALB—metabolic syndrome X	9.97e-06	0.000308	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—ALB—metabolic syndrome X	9.88e-06	0.000306	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—NOS3—metabolic syndrome X	9.53e-06	0.000295	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—NOS3—metabolic syndrome X	9.45e-06	0.000292	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	8.72e-06	0.00027	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	8.64e-06	0.000267	CbGpPWpGaD
Flecainide—CYP2D6—Metabolism—AKT1—metabolic syndrome X	4.38e-06	0.000136	CbGpPWpGaD
Flecainide—CYP2C9—Metabolism—AKT1—metabolic syndrome X	4.34e-06	0.000134	CbGpPWpGaD
